Lung Lavage Granulocyte Patterns and Clinical Phenotypes in Children with Severe, Therapy-Resistant Asthma
- PMID: 30654199
- PMCID: PMC6612461
- DOI: 10.1016/j.jaip.2018.12.027
Lung Lavage Granulocyte Patterns and Clinical Phenotypes in Children with Severe, Therapy-Resistant Asthma
Abstract
Background: Children with severe asthma have frequent exacerbations despite guidelines-based treatment with high-dose corticosteroids. The importance of refractory lung inflammation and infectious species as factors contributing to poorly controlled asthma in children is poorly understood.
Objective: To identify prevalent granulocyte patterns and potential pathogens as targets for revised treatment, 126 children with severe asthma underwent clinically indicated bronchoscopy.
Methods: Diagnostic tests included bronchoalveolar lavage (BAL) for cell count and differential, bacterial and viral studies, spirometry, and measurements of blood eosinophils, total IgE, and allergen-specific IgE. Outcomes were compared among 4 BAL granulocyte patterns.
Results: Pauci-granulocytic BAL was the most prevalent granulocyte category (52%), and children with pauci-granulocytic BAL had less postbronchodilator airflow limitation, less blood eosinophilia, and less detection of BAL enterovirus compared with children with mixed granulocytic BAL. Children with isolated neutrophilia BAL were differentiated by less blood eosinophilia than those with mixed granulocytic BAL, but greater prevalence of potential bacterial pathogens compared with those with pauci-granulocytic BAL. Children with isolated eosinophilia BAL had features similar to those with mixed granulocytic BAL. Children with mixed granulocytic BAL took more maintenance prednisone, and had greater blood eosinophilia and allergen sensitization compared with those with pauci-granulocytic BAL.
Conclusions: In children with severe, therapy-resistant asthma, BAL granulocyte patterns and infectious species are associated with novel phenotypic features that can inform pathway-specific revisions in treatment. In 32% of children evaluated, BAL revealed corticosteroid-refractory eosinophilic infiltration amenable to anti-TH2 biological therapies, and in 12%, a treatable bacterial pathogen.
Keywords: Asthma phenotypes; Bronchoalveolar lavage; Severe asthma.
Copyright © 2019 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Figures
Comment in
-
Airway Inflammatory Patterns in Severe Childhood Asthma-How Might This Change General Practice?J Allergy Clin Immunol Pract. 2019 Jul-Aug;7(6):1813-1814. doi: 10.1016/j.jaip.2019.04.017. J Allergy Clin Immunol Pract. 2019. PMID: 31279464 No abstract available.
References
-
- The Childhood Asthma Management Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000; 343: 105401063. - PubMed
-
- Fitzpatrick AM, Teague WG, Meyers DA, Peters SP, Li X, Li H, Wenzel SE, Castro M, Becharier L, Gaston BM, Bleecker ER, Moore WC. Heterogeneity of severe asthma in childhood: Confirmation by cluster analysis of children in the NIH/NHLBI Severe Asthma Research Network. J Allergy Clin Immunol, 2011; 127: 382–89. - PMC - PubMed
-
- Fleming L, Murray C, Bansal AT, Hashimoto S, Bisgaard H, Bush A, Frey U, Hedlin G, Singer F, van Aalderen W, Vissing NH, Zolkpili Z, Selby A, Fowler S, Shaw D, Chung KF, Sousa AR, Wagers S, Corfield J, Pandis I, Rowe A, Formaggio E, Sterk PJ, Roberts G, on behalf of the U-BIOPRED Study Group. The burden of severe asthma in childhood and adolescence: Results from the paediatric U-BIOPRED cohorts. Eur Respir J 2015; 46:1322–1333. - PubMed
-
- Teague WG, Phillips BR, Fahy JV, Wenzel SE, Fitzpatrick AM, Moore WC, Hastie AT, Bleecker ER, Meyers DA, Peters SP, Castro M, Coverstone AM, Bacharier LB, Ly NP, Peters MC, Denlinger LC, Ramratnam S, Sorkness RL, Gaston BM, Erzurum SC, Comhair SAA, Ross EM, Zein J, DeBoer MD, Irani AM, Israel E, Levy B, Cardet JC, Phipatanakul W, Gaffin JM, Holguin F, Fajt ML, Aujla SH. Mauger DT, Jarjour NN. Baseline features of the Severe Asthma Research Program (SARPIII) Cohort: Differences with age. J Allergy Clin Immunol in Practice, 2017. August 30pii:S2213–2198(17)30526–3. - PMC - PubMed